Cargando…
Incomplete Subacute Transverse Myelitis Following Vaccination With Pfizer-BioNTech COVID-19 mRNA Vaccine: A Case Report
In response to the coronavirus disease 2019 (COVID-19) pandemic, rapid development, clinical testing, and regulatory approval of vaccines occurred. The tozinameran COVID-19 vaccine is the first mRNA vaccine approved for use in humans. Transverse myelitis is a rare inflammatory disorder of the spinal...
Autores principales: | Alabkal, Jarrah, Rebchuk, Alexander D, Lyndon, Daniel, Randhawa, Nikkie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8760850/ https://www.ncbi.nlm.nih.gov/pubmed/35070526 http://dx.doi.org/10.7759/cureus.20460 |
Ejemplares similares
-
MRI Negative Myelitis Induced by Pfizer-BioNTech COVID-19 Vaccine
por: Cabral, Gonçalo, et al.
Publicado: (2022) -
Transverse myelitis as a first event of multiple sclerosis precipitated by Pfizer-BioNTech COVID-19 vaccination
por: Guarnaccia, J, et al.
Publicado: (2022) -
Subacute thyroiditis post-Pfizer-BioNTech mRNA vaccination for COVID-19
por: Khan, Farooq, et al.
Publicado: (2021) -
A Rare Case of Longitudinally Extensive Transverse Myelitis Following Pfizer-BioNTech COVID-19 Vaccination with a Favourable Outcome
por: KC, Ojbindra, et al.
Publicado: (2022) -
Myocarditis with Pfizer-BioNTech's COVID-19 vaccine in Israel
Publicado: (2021)